GoodRx Holdings, Inc.

Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx first quarter 2021 earnings call. As a reminder, today's conference call is being recorded. I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.

Thank you, operator. Good afternoon, everyone, and welcome to GoodRx's earnings conference call for the first quarter of 2021. Joining me today are Doug Hirsch and Trevor Bedbeck, our co-founders and co-Chief Executive Officers, and Carson Bowerman, our Chief Financial Officer. Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding management's plans, strategies, goals, and objectives, our market opportunity, our anticipated financial performance, and the expected impact of COVID-19 on our business. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties, and other important factors. These factors may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Factors discussed in the risk factor section of our quarterly report on Form 10-Q for the quarter ended March 31st and our other filings with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made on this call. Any such forward-looking statements represent management estimates as of the date of this call, and we disclaim any obligation to update these statements, even if subsequent events cause our views to change. In addition, we may also reference certain non-GAAP metrics. which are reconciled to the nearest gap metric in the company's shareholder letter, which can be found on the overview page of our investor relations website at investors.gooderx.com. I'd also like to remind everyone that a replay of this call will become available there shortly as well. With that, I'll turn the call over to Doug.

Thank you, Whitney, and thanks to all of you for joining us this afternoon. I want to take a minute to talk about trust. In healthcare, trust is really, really hard to earn, America's convoluted healthcare system is so complex, frustrating, and opaque that consumers increasingly question the guidance they receive. Am I getting the best care? Do I really need this treatment? Can I afford this? When Trevor and I started GoodRx, we didn't know much about healthcare, but we knew that there was a huge lack of trust. It seemed that the industry's motives rarely aligned with the needs of the patient, leading to complicated terms, hidden information, surprise bills, and lots of bad experiences. We knew that we would build products that put the patient's needs first. So we designed GoodRx to provide simple, easy-to-understand savings and assistance without asking for much in return. We embraced transparency and education as core tenets of our relationship with consumers. We even created a team of patient advocates to help guide consumers to the best outcomes. Fast forward to late 2020. With the miraculous development of multiple COVID-19 vaccines, we recognized our crucial role in the next step of the process. be a trusted resource to help Americans figure out where, when, and how to get vaccinated. The GoodRx COVID-19 Vaccine Guide went from concept to launch in just three weeks. Using government data and working with numerous stakeholders, we built a centralized service that tracks vaccine inventory and appointments at thousands of locations across the nation. We alert over 2.5 million people when eligibility changes in their state or county, and we publish comprehensive information about the virus, vaccines, and treatments people can reference easily. So far, more than 15 million people have visited our vaccine guide since launch. We anticipated the need and leveraged our capabilities to quickly develop a solution that empowered consumers to take action. Our obsession with improving the user experience in healthcare drives the development of everything we do. We're constantly asking our consumers about their healthcare pain points and then imagining ways to address them. We build relationships that turn a transaction into a relationship rooted in trust. This is why GoodRx Gold, our paid subscription program continues to be a strategic priority. Most people join Gold to find even greater savings on prescriptions. Then, we build tighter relationships with members by anticipating and solving additional health care needs. For example, Gold subscribers are presented with mail-order pharmacy options, exclusive discounts on online doctor visits through the GoodRx app, and dedicated customer support as well as a more personalized and customized experience. We believe these types of benefits drive acquisition and conversion, which has fueled subscriber growth and consumer savings. We're proud to say that between the family and individual plans being offered across GoodRxGold and the KrogerRx Savings Club, our 931,000 subscription plans translate to over 1.4 million Americans who benefit from these subscription programs. We are solving more pain points and building trust with more people every day. With 5.7 million monthly active consumers, 1.4 million Americans on nearly 1 million subscription plans, and thousands more using our telehealth services every month, we are clearly on to something. Almost 20 million monthly visitors came to GoodRx this quarter to compare prices, learn about healthcare, reference our vaccine guide, or use our manufacturer solutions platform. And we're just beginning. As the pandemic recedes, we will still be faced with America's existing healthcare crisis, so we are accelerating the development of new products and services to provide better ways for Americans to find the care they need. We're proud to report that consumers have now saved $30 billion using GoodRx while we maintain high MPS scores with both consumers and providers and a 4.8 app rating for GoodRx. This dynamic has driven a value to stakeholders across the entire healthcare ecosystem. We believe we have barely scratched the surface of this opportunity to transform healthcare for all Americans. Consumers' needs are evolving and they are seeking new ways to access their healthcare. Our goal for GoodRx is to be there for them as a trusted resource for each step of the journey. With the strength of our brand, our increasing reach, commitment to our mission, and the value we continue to create for consumers, we believe we are well positioned to win across the $4 trillion healthcare ecosystem in 2021 and beyond. With that, I'll turn it over to Trevor to address key highlights from the quarter and trends in our business. Thank you, Doug.